Advancements in Genetic Engineering: Revolutionizing Biotechnology for Disease Treatment
Keywords:
genetic engineering, CRISPR Cas9, gene therapy, biotechnology, disease treatment, precision medicine, ethical issuesAbstract
Genetic engineering has rapidly transformed modern biotechnology, offering unprecedented tools for understanding, diagnosing, and treating human diseases. Innovations such as CRISPR‑Cas systems, gene therapy vectors, and recombinant DNA technologies have revolutionized approaches to previously intractable conditions including genetic disorders, cancers, and viral infections. This article reviews key advancements in genetic engineering techniques, highlights their therapeutic applications, discusses ethical and regulatory challenges, and explores future directions for genetic interventions in medicine. The integration of functional genomics with precision editing has accelerated the development of personalized therapies that promise greater efficacy and reduced side effects. While challenges remain, continued interdisciplinary research is driving the translation of genetic engineering from bench to bedside.
References
Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR Cas9. Science, 346(6213), 1258096.
Jinek, M. et al. (2012). A programmable dual RNA guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821.
High, K. A., & Roncarolo, M. G. (2019). Gene therapy. New England Journal of Medicine, 381(5), 455–464.
Porteus, M. H. (2015). Towards a new era in medicine: therapeutic genome editing. Genome Biology, 16, 286.
Wang, D., et al. (2019). CRISPR based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell, 181(1), 136–150.
Cox, D. B., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: prospects and challenges. Nature Medicine, 21(2), 121–131.
Yin, H., et al. (2016). Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nature Biotechnology, 34(1), 76–81.
Roth, J. A. (2019). Gene therapy for cancer: what have we learned? Annual Review of Medicine, 70, 1–14.
Hendel, A., et al. (2015). Chemically modified guide RNAs enhance CRISPR Cas genome editing in primary human cells. Nature Biotechnology, 33, 985–989.
Naldini, L. (2015). Gene therapy returns to centre stage. Nature, 526, 351–360.
Frangoul, H., et al. (2021). CRISPR Cas9 mediated gene editing for sickle cell disease and β thalassemia. New England Journal of Medicine, 384, 252–260.
Ishino, Y., et al. (2018). History of CRISPR Cas from its discovery to genome editing. Journal of Bacteriology, 200(7), e00559 17.
Ahmad, N. R. (2025). Exploring the role of digital technologies in enhancing supply chain efficiency: A case study of e-commerce companies. Indus Journal of Social Sciences, 3(1), 226–237. https://doi.org/10.59075/ijss.v3i1.618
Ahmad, N. R. (2025). Exploring the impact of inflation on Pakistani society: Challenges, causes, and long-term consequences for economic stability and social well-being. Advance Journal of Econometrics and Finance, 2(4), 18–26. https://doi.org/10.63075/7vtnh777
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Omar Riaz, Sana Mirza
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in The Nature are licensed under an open access policy, allowing free and unrestricted access to the content. Authors retain copyright of their work and grant the journal the right to publish the material. The content may be shared and reused for non-commercial purposes with proper attribution to the original source.
